Medicare Enrolled
Dr. Paul Swanson, MD
Hematology & Oncology · Port St Lucie, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Swanson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swanson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Swanson
Dr. Paul Swanson is a hematology & oncology specialist in Port St Lucie, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Swanson performed 180,706 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Swanson received a total of $5,445 from 47 pharmaceutical and/or device companies across 354 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swanson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in FL
$5,445 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗180,706
Medicare services
Top 3% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
48,000 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
42,330 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 29,800 | $43 | $91 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
16,380 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $19 | $30 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,375 | $0 | $1 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,270 | $23 | $94 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,241 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,220 | $6 | $20 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,168 | $26 | $65 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,959 | $8 | $30 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,180 | $6 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,084 | $69 | $210 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,029 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,939 | $10 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,310 | $1 | $10 |
| Leuprolide injectable, camcevi, 1 mg | 672 | $68 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
666 | $11 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
524 | $105 | $330 |
| Anti-nausea injection (ondansetron/Zofran) | 488 | $0 | $2 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
425 | $6 | $20 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
362 | $24 | $85 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
346 | $13 | $55 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
332 | $66 | $165 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
322 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
299 | $99 | $300 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
284 | $13 | $40 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
243 | $9 | $25 |
| Iron level test | 242 | $6 | $20 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
225 | $1 | $6 |
| PSA test (prostate cancer screening) | 201 | $18 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
190 | $52 | $150 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
190 | $2 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
189 | $1 | $4 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
175 | $59 | $125 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
174 | $11 | $40 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
167 | $26 | $125 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
166 | $23 | $80 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
156 | $19 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 146 | $137 | $438 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
134 | $1 | $2 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
130 | $53 | $165 |
| New patient office visit, complex (60-74 min) | 97 | $174 | $520 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
93 | $144 | $460 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
92 | $17 | $50 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
90 | $24 | $85 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 89 | $20 | $60 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
89 | $3 | $10 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
81 | $15 | $50 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
69 | $8 | $25 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
67 | $43 | $366 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
64 | $4 | $12 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
64 | $1 | $4 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
63 | $4 | $15 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 57 | $407 | $681 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
52 | $14 | $55 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
51 | $1,196 | $5,700 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
50 | $20 | $50 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
48 | $83 | $1,075 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
45 | $7 | $20 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
45 | $19 | $55 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
36 | $5 | $15 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
36 | $4 | $7 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
36 | $46 | $140 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
34 | $4 | $20 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
30 | $75 | $165 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
28 | $8 | $25 |
| Stool test for blood A laboratory test that checks a stool sample for hidden blood using a chemical reaction. This test helps detect bleeding in the digestive tract. |
27 | $4 | $10 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
25 | $58 | $700 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
20 | $4 | $10 |
| Liver function blood test panel | 18 | $7 | $25 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
17 | $211 | $1,450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
24.4% high complexity
68.3% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,445
Total received (2018-2024)
Avg $778/year across 7 years
Top 47% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
354
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$174
2023
$232
2022
$177
2021
$59
2020
$526
2019
$2,223
2018
$2,054
Payments by company (2024)
Incyte Corporation
$44
Kite Pharma, Inc.
$42
Gilead Sciences, Inc.
$36
ABBVIE INC.
$20
GlaxoSmithKline, LLC.
$18
Janssen Biotech, Inc.
$15
Top 3 companies account for 70.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$750
Amgen Inc.
$703
Novartis Pharmaceuticals Corporation
$465
PFIZER INC.
$382
Merck Sharp & Dohme Corporation
$372
E.R. Squibb & Sons, L.L.C.
$283
AstraZeneca Pharmaceuticals LP
$281
Genentech USA, Inc.
$217
Lilly USA, LLC
$181
Astellas Pharma US Inc
$119
AbbVie, Inc.
$108
Incyte Corporation
$99
Takeda Pharmaceuticals U.S.A., Inc.
$98
Celgene Corporation
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
TESARO, Inc.
$91
GlaxoSmithKline, LLC.
$88
Gilead Sciences, Inc.
$83
Alexion Pharmaceuticals, Inc.
$77
Kite Pharma, Inc.
$59
Ipsen Biopharmaceuticals, Inc
$56
Bayer HealthCare Pharmaceuticals Inc.
$47
Janssen Pharmaceuticals, Inc
$46
Grifols USA, LLC
$44
Aurobindo Pharma USA, Inc.
$41
GENZYME CORPORATION
$39
Eisai Inc.
$38
EISAI INC.
$38
Taiho Oncology, Inc.
$38
ABBVIE INC.
$35
Verastem, Inc.
$34
Advanced Accelerator Applications
$34
Puma Biotechnology, Inc.
$30
Rigel Pharmaceuticals, Inc.
$30
Dova Pharmaceuticals
$30
Seattle Genetics, Inc.
$30
Pharmacyclics LLC, An AbbVie Company
$28
JAZZ PHARMACEUTICALS INC.
$23
Coherus Biosciences Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$19
Daiichi Sankyo Inc.
$18
INSYS Therapeutics Inc
$16
Agios Pharmaceuticals, Inc.
$16
Seagen Inc.
$15
Spectrum Pharmaceuticals Inc.
$13
Otsuka America Pharmaceutical, Inc.
$12
TOLMAR Pharmaceuticals, Inc.
$11
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Avastin · BOSULIF · CALQUENCE · CHANTIX · CYRAMZA · Copiktra · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · ERLEADA · Erleada · FASLODEX · Folotyn · GAZYVA · GILOTRIF · Gamunex-C · Halaven · IBRANCE · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · OPDIVO · PIQRAY · PROMACTA · Pomalyst · Prolia · REBLOZYL · Revlimid · SANDOSTATIN · SANDOSTATIN LAR · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tarceva · Tavalisse · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
24
County median income
$69,027
Nearest hospital to ZIP centroid (approximate)
ST LUCIE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Swanson is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Swanson experienced with filgrastim-ayow biosimilar injection, 1 microgram?
Based on Medicare claims data, Dr. Swanson performed 48,000 filgrastim-ayow biosimilar injection, 1 microgram services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Swanson receive payments from pharmaceutical companies?
Yes. Dr. Swanson received a total of $5,445 from 47 companies across 354 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swanson's costs compare to other hematology & oncology specialists in Port St Lucie?
Dr. Swanson's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swanson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Port St Lucie
Browse hematology & oncology specialists in Port St Lucie ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology